Page last updated: 2024-11-12

thioviridamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

thioviridamide: an antineoplastic antibiotic isolated from Streptomyces olivoviridis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11722272
MeSH IDM0497235

Synonyms (1)

Synonym
thioviridamide

Research Excerpts

Overview

Thioviridamide is a ribosomally synthesized and post-translational modified peptide (RiPP) produced by Streptomyces olivoviridis NA005001. It is active against a number of cancer cell lines.

ExcerptReferenceRelevance
"Thioviridamide is a structurally novel ribosomally synthesized and post-translational modified peptide (RiPP) produced by Streptomyces olivoviridis NA005001. "( A Genomics-Based Approach Identifies a Thioviridamide-Like Compound with Selective Anticancer Activity.
Cappello, AR; Frattaruolo, L; Lacret, R; Truman, AW, 2017
)
2.17
"Thioviridamide is a structurally unique ribosomally synthesized and post-translationally modified peptide that contains several thioamide bonds and is active against a number of cancer cell lines. "( Thioholgamides: Thioamide-Containing Cytotoxic RiPP Natural Products.
Adam, S; Herrmann, J; Kjaerulff, L; Koehnke, J; Müller, R; Sikandar, A; Zaburannyi, N, 2017
)
1.9
"Thioviridamide is a unique peptide antibiotic containing five thioamide bonds from Streptomyces olivoviridis. "( Cloning and heterologous expression of the thioviridamide biosynthesis gene cluster from Streptomyces olivoviridis.
Hayakawa, Y; Izawa, M; Kawasaki, T, 2013
)
2.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's10 (71.43)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]